Big business and surgery: Who belongs in your operating room

The operating room (OR) is supposed to be a tightly choreographed, high-stakes dance: sterile field, sharp instruments, people speaking in calm voices while doing things that would make the rest of us lie down immediately. So it’s fair to ask: who exactly should be in there?

If your mental picture includes only the surgeon, anesthesiologist, nurses, and a tray of instruments that looks like it was designed by a medieval blacksmithwelcome to the modern era. Today’s OR often includes students, trainees, equipment techs, and sometimes people who are not hospital employees at all: medical device representatives, surgical technology specialists, and other “health care industry representatives” (HCIRs). Meanwhile, outside the doors, big business influences what happens inside: supply contracts, private equity consolidation, staffing models, and productivity targets.

This article breaks down the real-world intersection of business and surgerywithout the corporate buzzwordsand offers a practical answer to the question: who belongs in your operating room, and under what rules?

First, define “belongs”: essential vs. non-essential OR personnel

In the simplest terms, OR personnel fall into two buckets: (1) essential for direct patient care and safety, and (2) non-essential individuals whose presence must be justified, controlled, and disclosed.

Essential OR team members

• Surgeon(s) and assisting surgeons (including fellows/residents when appropriate)
• Anesthesia professional(s) (anesthesiologist, CRNA, anesthesia assistants, anesthesia techs)
• Scrub personnel (scrub nurse/tech handling instruments and sterile field)
• Circulating nurse (non-sterile coordination, documentation, patient advocacy)
• Additional clinical support when clinically necessary (e.g., perfusionist for cardiac cases)

“Conditional” OR participants

These people may belong in the OR sometimes, but only when there’s a clear patient-care rationale and proper oversight:

• Trainees (students, residents, fellows) under supervision and according to policy
• Hospital employees supporting equipment (biomed, radiology techs, robotics support)
• Industry representatives (device reps, implant reps, surgical equipment specialists)
• Observers (rare; often require special approval and explicit patient permission)

The key concept is this: the OR is not a spectator sport. If someone is there, it should be because their presence improves safety, helps the team use equipment correctly, or supports the patient’s care plannot because they brought donuts or have a really confident handshake.

The device rep question: helpful teammate or uninvited extra?

Let’s talk about the most debated non-employee in the room: the medical device representative. In many U.S. hospitals, reps are present during procedures involving specialized implants or complex technology (think orthopedic implants, spine hardware, or certain surgical robotics setups). Their practical value is real: they know the equipment, they know the sizes, and they can troubleshoot quickly when something goes sideways.

Professional guidance in the U.S. generally treats reps as visitors with a narrow technical role, not clinical staff. In other words: they can help you run the tool, but they shouldn’t be “running the case.”

Where device reps can add value

• Technical guidance on device setup, implant options, instrumentation steps, and compatibility (especially when new systems are introduced)
• Real-time troubleshooting if specialized equipment fails or behaves oddly
• Supply coordination (confirming implant availability, backup sizes, missing trays)
• Education and training for the team on device updatesideally outside the live case, but reality is messy

Where the line gets blurry (and risky)

The biggest concern is “role creep”: when technical support drifts into something that looks like clinical decision-making or direct influence over the procedure. Ethics discussions in U.S. medicine have raised concerns that, in some settings, reps may be asked to answer questions that should be within the surgical team’s trainingor their input may substitute for adequate staff preparation.

That’s not a knock on reps as people. It’s a systems problem: if the OR relies on a company employee to make the procedure run, you’ve built a fragile workflow with a conflict-of-interest landmine in the middle.

Big business influences inside the OR (even when business isn’t in the room)

You can keep every rep outside the doors and still have big business shaping the OR. That influence shows up through ownership structures, contracting, staffing models, and performance incentives.

1) Contracts and “standardization” (a.k.a. the spreadsheet decides your suture)

Hospitals negotiate pricing with device manufacturers and distributors through supply contracts and group purchasing arrangements. Standardization can be goodfewer product variations can reduce errors and streamline training. But it can also create tension when surgeons prefer a different implant system or believe a specific tool is clinically superior for a given patient.

The uncomfortable truth is that the OR is both a clinical environment and a major revenue center. High-cost implants and device choices matter financially, so leadership often wants predictable purchasing patterns. The risk is that “predictable” becomes a euphemism for “whatever fits the contract,” rather than “what fits the patient.”

2) Private equity and consolidation: who owns the practice, and what changes?

Private equity (PE) investment has expanded across healthcare services, including physician practices and surgery-adjacent areas like anesthesia and ambulatory surgery centers. Consolidation can bring capital, management support, and growth strategies. It can also bring pressure: increased case volume targets, cost-cutting, tighter staffing, and aggressive billing strategies.

Research on PE ownership in healthcare has reported concerning associations in some settingssuch as increases in certain adverse events at PE-acquired hospitals and price increases associated with consolidation in specialties like anesthesia in some markets. The OR impact is often indirect but real: staffing ratios, turnover, training budgets, and equipment decisions can shift when financial priorities move to the foreground.

3) Metrics, productivity, and the “fast OR” problem

Turnover time, first-case on-time starts, block utilizationthese metrics can be useful. But when metrics dominate, you risk creating an OR culture where speed outruns safety. In that environment, a device rep can look tempting: “They’ll help us go faster.” That’s exactly when you need rules that keep the clinical team in control.

So who belongs? A practical decision framework

Here’s a straightforward way to decide whether a non-employee (or any non-essential person) belongs in the OR for a given case. If the answer to any of these is “no,” pause the invite.

Question 1: Is their presence clinically justified for this patient and this procedure?

“They’re usually here” is not a justification. A better standard: “Their technical expertise reduces risk, prevents a delay, or supports correct device use.”

Question 2: Are they credentialed and trained for OR access?

Many U.S. hospitals use vendor credentialing programs to verify immunizations, training (e.g., HIPAA/privacy), background checks, and site-specific rules. Credentialing doesn’t make someone clinical staffit simply confirms they meet baseline requirements to enter patient-care areas.

Question 3: Do they have a defined role and clear limits?

The safest approach is to define scope in plain language: technical support only, no hands-on patient care, no sterile field participation unless explicitly permitted by policy (and even then, it’s typically very restricted), and no independent decision-making.

Question 4: Has the patient been informed appropriately?

Patients reasonably assume that the people in the OR are there for their care. If a non-employee will be present, transparency matters. Many professional guidelines emphasize informing patients about the presence and purpose of industry representatives and protecting privacy and confidentiality.

Question 5: Is the OR team comfortableand empowered to say “not today”?

OR culture matters. If nurses or anesthesia staff feel they can’t question an extra person in the room, that’s a safety problem. Anyone who is not essential should be removable without drama if patient safety, privacy, sterility, or workflow is at risk.

“Ground rules” for industry representatives in the operating room

If your facility allows HCIRs/device reps in the OR, the rules should be boring, specific, and enforceable. Boring is good. Boring is what you want around scalpels.

Recommended OR rules that protect patients and teams

• Written policy: role, supervision, permitted areas, and documentation requirements
• Credentialing and sign-in: verification, badge visibility, and tracking presence
• Time-limited presence: in the room only when their device is in active use or immediate setup is needed
• No patient contact: no touching the patient, no directing clinical care, no chart access unless explicitly authorized
• Privacy and confidentiality: no recording, no photos, no patient identifiers outside approved processes
• Sterile field boundaries: follow attire/traffic rules, maintain distance unless policy explicitly defines otherwise
• One boss: the perioperative leadership and surgeon lead decide; reps do not self-invite or override team workflow
• Stop-work authority: staff can ask anyone to step out if safety or sterility is threatened

A healthy OR policy also separates two types of education: training before the case (preferred) and live-case support (sometimes necessary). If “training” happens only during live cases, you’ve created a recurring risk: learning under pressure, with a patient on the table.

Specific examples: when “business” helps, and when it hurts

Example A: The helpful scenario

A hospital introduces a new orthopedic implant system. The surgical team is trained in advance, but in the first few cases, a rep is present to confirm instrument assembly and ensure backup implant sizes are available. The rep stays out of the sterile field, answers technical questions, and steps out once the implant is seated and the specialized instruments are no longer in use.

Result: fewer delays, fewer “we’re missing the 42mm” moments, and smoother adoptionwithout compromising team control.

Example B: The risky scenario

A surgeon relies on a rep to guide device selection and procedural steps mid-case because the team hasn’t been trained and the instruments are unfamiliar. The rep becomes the de facto navigator. Staff hesitate to challenge the rep’s directions because the rep “knows the system.”

Result: role confusion, potential conflict of interest, and a training gap that could surface as a patient safety event.

Example C: The big-business pressure cooker

An ownership change leads to tighter staffing and increased case targets. Turnover times become a performance obsession. Equipment changes happen quickly to align with purchasing contracts. More “support” personnel get invited into cases to prevent delayssometimes without a clear policy framework.

Result: the OR becomes a throughput machine. Safety may still be excellent (many teams pull it off), but the system becomes less resilient: one missing tray, one short-staffed day, one new product without trainingand the cracks show.

What patients should know (and what clinicians should document)

Patients rarely ask, “Will a device rep be in the room?”but many care about privacy, professionalism, and who has access to their body while they’re unconscious. The safest approach is to treat non-essential presence as something that should be explainable without defensiveness.

Clinically, documentation practices vary by facility, but a strong governance model typically includes:

• Verification of vendor credentialing/badging
• Recording non-essential personnel presence when required by policy
• Clear accountability for who invited them and why
• Privacy safeguards (no recordings, no unauthorized access)

Bottom line: the OR is a patient-care zone, not a marketplace

Business will always influence surgerytechnology costs money, staffing is expensive, and hospitals are complex organizations. The goal isn’t to pretend commerce doesn’t exist. The goal is to keep the clinical mission in charge.

If you remember one thing, make it this: Anyone in the operating room should be there because it improves patient care or safetyand their role should be defined, limited, credentialed, and transparent. That principle protects patients, supports staff, and keeps the OR from turning into the weirdest corporate site visit on earth.

Real-world experiences from the OR ecosystem

The most revealing “case studies” about business in surgery aren’t published in glossy reports. They’re the small moments OR teams talk about afterwardthe ones that feel mundane until you realize they’re exactly where safety and ethics live.

One common experience: the device tray surprise. A case starts with the best of intentions, and then someone discovers a missing instrument or a mismatched component. In many hospitals, the fastest path to resolving that is a call to the rep: they know which tray is needed, what’s compatible, and whether a substitute exists. Teams describe this as the difference between a short delay and a full stop. When reps are used this waylike technical librarians who can quickly find the right “book” without touching the “patient”their presence can feel like a practical safety net.

Another recurring experience is the new-tech learning curve. OR teams often do training sessions, but the first few real cases still bring anxiety: different instrument handles, different sizing logic, different steps. In those first cases, a rep’s calm “Here’s the sequence” can reduce cognitive load on the teamespecially the scrub tech who is juggling requests while maintaining the sterile field. Teams often say the best reps are the ones who understand the OR rhythm: they speak briefly, only when asked, and they never compete for attention during critical moments.

But there’s also the flip side: stories about role confusion. In some environments, a rep becomes the person everyone turns to automatically, and that changes the social dynamics in the room. A circulating nurse may hesitate to push back on an extra rep who keeps drifting closer to the field, or a newer staff member may assume the rep’s guidance is “official” because it’s confident. These are not dramatic scandals; they’re subtle cultural shifts. And subtle shifts are exactly how safety margins get thinner without anyone noticing.

Teams also talk about the business pressure that shows up as time pressure. When turnover time becomes the headline metric, the OR can feel like it’s on a timer from the moment the patient wheels in. In that atmosphere, extra people get invited because they might speed things up: a rep to ensure no sizing mistakes, a tech to manage equipment, a vendor to handle a proprietary console. The intention can be goodprevent delaysbut the risk is that the room becomes crowded and communication becomes noisier. Many experienced OR nurses will tell you: a crowded OR doesn’t just feel chaotic; it can literally increase the chances of breaking sterile technique or missing a critical detail.

Another lived experience is the “standardization whiplash” that happens after major contracting changes. Staff might train on one system, then switch to another because of a new contract or purchasing decision. Even when the change is financially necessary, it can create a short-term safety challenge: new labeling, new workflows, new failure modes. In that transition period, reps often appear more frequentlynot as an ethical problem by default, but as a sign that the system is absorbing a change too quickly. The lesson many teams draw is practical: if you’re changing products, you have to fund training time and protect staffing levels, or you’ll end up “learning live,” which nobody truly wants.

The best OR cultures tend to treat these experiences as feedback loops. If reps are repeatedly needed to “save” cases, that’s a signal to improve training and inventory processes. If reps are frequently present, that’s a cue to audit consent and policy compliance. If business pressures are escalating, that’s the moment to re-center the patient: fewer distractions, clearer roles, better preparation. In the end, the most valuable “experience” is the one teams build on purpose: a disciplined OR where industry support is available when truly needed, but the clinical team always owns the care.